mesalamine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Chemotherapy-Induced Febrile Neutropenia: FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frattini, F | 1 |
| Crestani, S | 1 |
| Vescovi, PP | 1 |
| Franchini, M | 1 |
1 other study available for mesalamine and Chemotherapy-Induced Febrile Neutropenia
| Article | Year |
|---|---|
Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemotherapy-Induced Febrile Neutropenia; Colitis, Ulcerati | 2013 |